| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/30/2004 | EP1432706A2 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
| 06/30/2004 | EP1432705A2 Dual action antibiotics |
| 06/30/2004 | EP1432698A2 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
| 06/30/2004 | EP1432678A1 Hiv protease inhibitors |
| 06/30/2004 | EP1432677A1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same |
| 06/30/2004 | EP1432459A1 Inhibition of exoprotein production using aromatic compositions |
| 06/30/2004 | EP1432452A2 Inhibition of stat-1 |
| 06/30/2004 | EP1432449A1 Water-in-oil emulsions comprising vinyl polymers carrying acidic groups in side chains, compositions, and methods |
| 06/30/2004 | EP1432441A2 Use of hmgb1 for the activation of dendritic cells |
| 06/30/2004 | EP1432435A1 Enamel matrix protein compositions for modulating immune response |
| 06/30/2004 | EP1432431A2 Methods and compositions for modulating interleukin-21 receptor activity |
| 06/30/2004 | EP1432427A1 Composition of hypochlorous acid and its applications |
| 06/30/2004 | EP1432418A1 Treatment of hepatitis b virus infection with human monoclonal antibodies |
| 06/30/2004 | EP1432416A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 06/30/2004 | EP1432408A1 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 06/30/2004 | EP1206281B1 Formulation containing moxifloxacin and sodium chloride |
| 06/30/2004 | EP1169063B1 Treatment of intracellular infection |
| 06/30/2004 | EP1113802B1 Antiviral combinations of lamivudine and adefovir |
| 06/30/2004 | EP1112366B1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
| 06/30/2004 | EP0971908B1 Il-8 receptor antagonists |
| 06/30/2004 | EP0958289B1 Amino acid ester containing azole antifungals |
| 06/30/2004 | EP0564532B1 Polypeptides derived from proteins of the hepatitis c virus |
| 06/30/2004 | CN1509337A New polynucleotides and polypeptides of IFN alpha-17 gene |
| 06/30/2004 | CN1509328A Use of opg ligand to modulate immune response |
| 06/30/2004 | CN1509288A The citrate salt of 5,8,14-triazatetracyclo (10.3.1.0.2,11.0.4,9)-hexadeca-2.(11),3,5,7,9-pentaene |
| 06/30/2004 | CN1509271A 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for treatment of pain anxiety or gastrointestinal disorders |
| 06/30/2004 | CN1509196A 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor |
| 06/30/2004 | CN1509188A Immunoconjugates made of egg-yolk antibiodies (IGY), production and use thereof in diagnoses and therapy |
| 06/30/2004 | CN1509186A Composition containing epigallocatechin gallate |
| 06/30/2004 | CN1509178A Pharmaceutical composition comprising lysophosphatidic acid |
| 06/30/2004 | CN1509174A Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 06/30/2004 | CN1508141A Nucleotide sequence for anti HIV infection and preventing AIDS and use thereof |
| 06/30/2004 | CN1507916A Compositions comprising neisseria meningitidis antigens from serogroups B and C, and other antigens |
| 06/30/2004 | CN1507896A Chinese medicime liposome for treating viral hepatitis B and preventing liver cell from fibriform and preparing method thereof |
| 06/30/2004 | CN1507894A Medicine for treating gastrointestinal summer damp cold and preparing method thereof |
| 06/30/2004 | CN1507885A Medicinal formula of calculus bovis cold-clearing capsule |
| 06/30/2004 | CN1507881A Oral preparation of chinese medicine 'kekeping' for treating cold |
| 06/30/2004 | CN1507862A Complex acetaminophen vitamin C dispersion tablet and preparing method thereof |
| 06/30/2004 | CN1507858A Flrorinated chloromycetin containing liquid preparation for animal |
| 06/30/2004 | CN1507854A Amphotericin B Liposome and preparing method thereof |
| 06/30/2004 | CN1507850A Formulation of toothpaste with antivirus action and preparing method thereof |
| 06/30/2004 | CN1155710C Recombinant herpesvirus with the use of gB Gene promoter |
| 06/30/2004 | CN1155708C DNA of encoding plasminogen excited protein |
| 06/30/2004 | CN1155707C Vaccines for plague |
| 06/30/2004 | CN1155603C Process for producing 3-cephem compounds |
| 06/30/2004 | CN1155571C Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 06/30/2004 | CN1155406C Nitrogen oxide generation inhibitor |
| 06/30/2004 | CN1155402C Compounds that inhibit interaction between signal-transducing proteins and GLGF(PDZ/DHR) domain and uses thereof |
| 06/30/2004 | CN1155388C Orally administrable solid ribavirin dosafe forms and process for making them |
| 06/30/2004 | CN1155374C Novel biological activity of proglumide |
| 06/29/2004 | US6756491 Receptor polypeptide for use in the treatment of urogenital disorders and cushing's syndrome |
| 06/29/2004 | US6756481 IL-23 receptor binding compositions |
| 06/29/2004 | US6756404 Autoinducer compounds |
| 06/29/2004 | US6756391 Antiviral compounds |
| 06/29/2004 | US6756382 Amide substituted imidazoquinolines |
| 06/29/2004 | US6756381 A purified antitumor agent is crystallized from acetone or dichloromethane |
| 06/29/2004 | US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis |
| 06/29/2004 | US6756371 Morpholino or thiomorpholino derivatives; respiratory system disorders |
| 06/29/2004 | US6756368 Having such as 1-imine-3-hydroxy-prop-1-ene and imidazole ligands; varicella-zoster, vesicular stomatitis, poliovirus, adenovirus |
| 06/29/2004 | US6756362 Anionic polymers including dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, dextran sulfate, pentosan polysulfate, hyaluronic acid and alginate. |
| 06/29/2004 | US6756361 Overcoming antibiotic resistance |
| 06/29/2004 | US6756359 Administering a 14 membered macrolide and ketolide antibiotics containing c12 modifications to a patient suffering from bacterial infections |
| 06/29/2004 | US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/29/2004 | US6756042 Salmonella vaccine; immunogenicity; reduced possibility of strain revertion to reactive form; safe; limited side effects |
| 06/29/2004 | CA2366304C Novel method of treatment |
| 06/29/2004 | CA2315230C Anti-cryptococcal peptides |
| 06/29/2004 | CA2285052C Improvements in or relating to long-acting antimicrobials |
| 06/29/2004 | CA2263913C Substituted 6,6-hetero-bicyclic derivatives |
| 06/29/2004 | CA2112399C Methods and compositions for treating malaria and other diseases |
| 06/27/2004 | CA2447378A1 Infection preventive or therapeutic agent and food |
| 06/24/2004 | WO2004053162A1 Method of distinguishing drug-resistance of hepatitis b virus |
| 06/24/2004 | WO2004052931A1 Negatively charged antiviral protein conjugates |
| 06/24/2004 | WO2004052906A1 Anhydrous crystalline azido cytosine hemisulfate derivative |
| 06/24/2004 | WO2004052905A2 Antiviral nucleoside derivatives |
| 06/24/2004 | WO2004052904A2 Novel semisynthetic macrolide antibiotics of the azalide series |
| 06/24/2004 | WO2004052892A1 Anhydrous crystalline form of valacyclovir hydrochloride |
| 06/24/2004 | WO2004052891A1 Heterocyclic compounds, preparation method thereof and use of same as medicaments, such as anti-bacterial medicaments and beta-lactamase inhibitors |
| 06/24/2004 | WO2004052890A1 Heterocyclic compounds, methods of making them and their use in therapy |
| 06/24/2004 | WO2004052879A1 Thiophenederivatives for the treatment of flavivirus infections |
| 06/24/2004 | WO2004052863A1 Anti-inflammatory agent |
| 06/24/2004 | WO2004052862A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 06/24/2004 | WO2004052857A1 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists |
| 06/24/2004 | WO2004052396A1 Vaccine comprising an antigen conjugated to low valency anti-cd40 or anti-cd28 antibodies |
| 06/24/2004 | WO2004052395A1 L2-peptide of the human papillomavirus associated with virus-like particles |
| 06/24/2004 | WO2004052394A1 Broad-spectrum lps based vaccines of unencapsulated strains of haemophilus influenzae and other pathogenic species of gram-negative bacteria |
| 06/24/2004 | WO2004052384A1 Antiviral, anti-infectious and cicatrising properties of extracts of dichrostachys glomerata |
| 06/24/2004 | WO2004052365A2 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 06/24/2004 | WO2004052363A1 Oxazolidinones used as antiviral agents, in particular for fighting against cytomegalovirus |
| 06/24/2004 | WO2004052313A2 Anti-infectives |
| 06/24/2004 | WO2004052288A2 2-nh-heteroarylimidazoles with antibacterial activity |
| 06/24/2004 | WO2004041862A3 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 06/24/2004 | WO2004031236A3 Therapeutic uspa1-derived peptides |
| 06/24/2004 | WO2004024925A3 Collectin-complement activating protein chimeras |
| 06/24/2004 | WO2004022716A3 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 06/24/2004 | WO2004016632A3 Lincomycin derivatives possessing antibacterial activity |
| 06/24/2004 | WO2004014304A3 Electrospun amorphous pharmaceutical compositions |
| 06/24/2004 | WO2004011650A3 Antigens encoded by alternative reading frame from pathogenic viruses |
| 06/24/2004 | WO2004011478A3 Anti-viral 7-deaza d-nucleosides and uses thereof |
| 06/24/2004 | WO2003103583A3 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 06/24/2004 | WO2003099221A3 Methods for using jnk inhibitors for treating or preventing disease-related wasting |